Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tarella

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Autoimmunity Reviews|December 11, 2012
Lymphocyte transformation and autoimmune disordersC Tarella, A Gueli, M Ruella, et al.
Experimental Cell Research|August 1, 1983
Functional and phenotypic characterization of two HL60 clones resistant to dimethylsulfoxideD Ferrero, E Gallo, L Lanfrancone, et al.
Leukemia|November 11, 1999
Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas: a critical reappraisal of molecular strategiesP Corradini, M Ladetto, A Pileri, et al.
Cancer Research|February 1, 1986
Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disordersD Ferrero, C Tarella, P Pregno, et al.
Journal of Cellular Physiology|January 1, 1985
Release of hemopoietic factors by normal human T cell lines with either suppressor or helper activityL Lanfrancone, D Ferrero, E Gallo, et al.
British Journal of Haematology|February 1, 1979
The importance of the genetic picture and globin synthesis in determining the clinical and haematological features of thalassaemia intermediaE Gallo, P Massaro, R Miniero, et al.
Haematologica|March 1, 1996
Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemiaM Ladetto, P Corradini, M Astolfi, et al.
Cancer Research|November 1, 1982
Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferationD Ferrero, C Tarella, E Gallo, et al.
Journal of Clinical & Laboratory Immunology|April 1, 1988
Immunological separation of two CFU-GM subsets showing different responsiveness to T-cell derived growth factorsC Tarella, D Ferrero, D Caracciolo, et al.
Medical Oncology (Northwood, London, England)|August 30, 2000
Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patientsM Ladetto, L Bergui, I Ricca, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Autoimmunity Reviews|December 11, 2012
Lymphocyte transformation and autoimmune disordersC Tarella, A Gueli, M Ruella, et al.
Experimental Cell Research|August 1, 1983
Functional and phenotypic characterization of two HL60 clones resistant to dimethylsulfoxideD Ferrero, E Gallo, L Lanfrancone, et al.
Leukemia|November 11, 1999
Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas: a critical reappraisal of molecular strategiesP Corradini, M Ladetto, A Pileri, et al.
Cancer Research|February 1, 1986
Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disordersD Ferrero, C Tarella, P Pregno, et al.
Journal of Cellular Physiology|January 1, 1985
Release of hemopoietic factors by normal human T cell lines with either suppressor or helper activityL Lanfrancone, D Ferrero, E Gallo, et al.
British Journal of Haematology|February 1, 1979
The importance of the genetic picture and globin synthesis in determining the clinical and haematological features of thalassaemia intermediaE Gallo, P Massaro, R Miniero, et al.
Haematologica|March 1, 1996
Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemiaM Ladetto, P Corradini, M Astolfi, et al.
Cancer Research|November 1, 1982
Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferationD Ferrero, C Tarella, E Gallo, et al.
Journal of Clinical & Laboratory Immunology|April 1, 1988
Immunological separation of two CFU-GM subsets showing different responsiveness to T-cell derived growth factorsC Tarella, D Ferrero, D Caracciolo, et al.
Medical Oncology (Northwood, London, England)|August 30, 2000
Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patientsM Ladetto, L Bergui, I Ricca, et al.
Pageof 9